Because wounds are a source of suffering, our mission as “the Healing Company” is to support healthcare professionals every day in delivering evidence-based treatments from the beginning so that life can start again for patients.
At Urgo Medical, we strongly believe that we can make a difference by:
· Putting patients at the heart. We give a voice to patients so we can understand their needs and adapt our solutions to better meet them.
· Being the professional’s partner. We work closely with scientific bodies and we develop educational programs to constantly improve knowledge in advanced wound care.
· Leading with Science. We continually invest in R&D and deliver robust clinical evidence because we believe in evidence-based treatments.
We can do it because our 1300 employees are passionate about making a difference for patients
Founded in 2011 by CEO John Ruprai, Ennogen is a licensed wholesaler and distributor of pharmaceuticals and medical devices to the UK and Europe as well as many countries in Asia, Africa and the Middle East. Since it was established, Ennogen has developed a differentiated portfolio of over 150 Market Authorisations, holds the ISO13485 accreditation and is the legal manufacturer and distributor of a range of medical devices including various barrier ointments, creams, soap substitutes and products to alleviate dry mouth conditions.
Flen Health believes biotech innovations can help to build a more secure life for all of us. We want to improve the quality of life of people suffering from inflammatory or infectious skin diseases such as wounds in a responsible way, by providing added value for patients, healthcare professionals, health authorities and society.
Flen Health was established in 2000, building on the results of wound-treatment research performed by it’s MD, Philippe Sollie, a pharmacist. Based on patented technologies, Flen Health develops and commercialises innovative skin and wound healing solutions.
We hold an ISO 13485 certificate that covers all our operations. Thanks to the success on the Belgian market, we initiated international expansion into further affiliates in Luxembourg, the Netherlands, Germany, UK, Ireland, USA and UAE, managed by 100+ motivated employees. Flen Health products are distributed in 30+ countries across the globe. UK product portfolio: Flaminal® Hydro, Flaminal® Forte, Flamigel® RT.
Integra Life Tissue Technology Advanced Woundcare team, Focus on our market-leading MEDIHONEY® line of Active Leptospermum Manuka Honey dressings, which offer antimicrobial activity and outstanding wound healing. The range includes Medihoney Barrier Cream and the Medihoney HCS dressings which combines a Hydrogel Sheet containing Super Absorbent Polymers,with Manuka Honey.
Also within our portfolio is TCC-EZ®, a unique patented, easy and quick to apply, off-loading system to help treat diabetic foot ulcers and charcot neuropathy.
HARTMANN is one of the leading providers of wound care products for patients and healthcare professionals around the world.
Innovation, partnership, and success are core to our business, as we continue to strive for more effective, cost-efficient, and smarter wound management solutions.
At HARTMANN, we’re committed to our partnership with healthcare professionals, to make complete wound care a reality for everyone.
We strongly believe in education, ensuring a highly skilled workforce support you, providing high-quality accessible training and education, delivered via our LINK programme for you and your organisation.
Accel-Heal Technologies Limited is a UK-based company that was established to continue the development of unique electrical stimulation products designed to help transform clinical and health economic outcomes in patients with painful and hard-to-heal wounds.
Electrical stimulation is one of the most evidence-based technologies in wound management with five meta analyses and over 30 RCTs published today.
The challenge has always been how to incorporate what has been perceived as a complex therapy, into a simple to use format in frontline clinical practice. Accel‑Heal, as a pre-programmed, single-use, wearable and easy to use electrical stimulation device, has been developed to address this challenge.